Atricure Stock Shares Outstanding
| ATRC Stock | USD 23.17 0.46 2.03% |
AtriCure fundamentals help investors to digest information that contributes to AtriCure's financial success or failures. It also enables traders to predict the movement of AtriCure Stock. The fundamental analysis module provides a way to measure AtriCure's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AtriCure stock.
As of April 24, 2024, Common Stock Shares Outstanding is expected to decline to about 24.2 M. AtriCure | Shares Outstanding |
AtriCure Company Shares Outstanding Analysis
AtriCure's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current AtriCure Shares Outstanding | 48.37 M |
Most of AtriCure's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AtriCure is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
AtriCure Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for AtriCure is extremely important. It helps to project a fair market value of AtriCure Stock properly, considering its historical fundamentals such as Shares Outstanding. Since AtriCure's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of AtriCure's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of AtriCure's interrelated accounts and indicators.
Click cells to compare fundamentals
AtriCure Shares Outstanding Historical Pattern
Today, most investors in AtriCure Stock are looking for potential investment opportunities by analyzing not only static indicators but also various AtriCure's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of AtriCure shares outstanding as a starting point in their analysis.
AtriCure Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
AtriCure Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, AtriCure has 48.37 M of shares currently outstending. This is 73.2% lower than that of the Health Care Equipment & Supplies sector and 43.68% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 91.54% higher than that of the company.
AtriCure Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AtriCure's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AtriCure could also be used in its relative valuation, which is a method of valuing AtriCure by comparing valuation metrics of similar companies.AtriCure is currently under evaluation in shares outstanding category among related companies.
AtriCure Fundamentals
| Return On Equity | -0.066 | ||||
| Return On Asset | -0.0324 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | (0.12) % | ||||
| Current Valuation | 1.04 B | ||||
| Shares Outstanding | 48.37 M | ||||
| Shares Owned By Insiders | 3.07 % | ||||
| Shares Owned By Institutions | 96.93 % | ||||
| Number Of Shares Shorted | 3.25 M | ||||
| Price To Earning | 33.47 X | ||||
| Price To Book | 2.50 X | ||||
| Price To Sales | 2.92 X | ||||
| Revenue | 399.25 M | ||||
| Gross Profit | 245.94 M | ||||
| EBITDA | (16.28 M) | ||||
| Net Income | (30.44 M) | ||||
| Cash And Equivalents | 118.45 M | ||||
| Cash Per Share | 2.55 X | ||||
| Total Debt | 74.49 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 3.66 X | ||||
| Book Value Per Share | 9.81 X | ||||
| Cash Flow From Operations | 4.42 M | ||||
| Short Ratio | 4.03 X | ||||
| Earnings Per Share | (0.66) X | ||||
| Price To Earnings To Growth | (1.18) X | ||||
| Target Price | 56.14 | ||||
| Number Of Employees | 1.2 K | ||||
| Beta | 1.37 | ||||
| Market Capitalization | 1.1 B | ||||
| Total Asset | 613.93 M | ||||
| Retained Earnings | (357.06 M) | ||||
| Working Capital | 191.68 M | ||||
| Current Asset | 74.75 M | ||||
| Current Liabilities | 31.59 M | ||||
| Net Asset | 613.93 M |
About AtriCure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AtriCure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AtriCure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AtriCure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with AtriCure
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AtriCure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AtriCure will appreciate offsetting losses from the drop in the long position's value.Moving together with AtriCure Stock
| 0.72 | DH | Definitive Healthcare Financial Report 2nd of May 2024 | PairCorr |
| 0.73 | FONR | Fonar | PairCorr |
Moving against AtriCure Stock
| 0.65 | IRIX | IRIDEX Financial Report 9th of May 2024 | PairCorr |
| 0.52 | STIM | Neuronetics Financial Report 14th of May 2024 | PairCorr |
| 0.42 | AGTI | Agiliti Sell-off Trend | PairCorr |
The ability to find closely correlated positions to AtriCure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AtriCure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AtriCure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AtriCure to buy it.
The correlation of AtriCure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AtriCure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AtriCure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AtriCure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out AtriCure Piotroski F Score and AtriCure Altman Z Score analysis. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |
Is AtriCure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.66) | Revenue Per Share 8.621 | Quarterly Revenue Growth 0.21 | Return On Assets (0.03) | Return On Equity (0.07) |
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.